Nad+ And Fatigue — Why Your Energy Crashes As You Age
Quick Read NAD+ is a molecule your cells need to produce energy. As you age, NAD+ levels drop significantly, partly
Subscribe to the distribution list, to get regular updates on supplement research for health,
🧠 NeuroBright Our evidence-based brain supplement formulated from 1.7M research papers
Homocysteine is a natural byproduct of protein metabolism that can accumulate in your blood and damage blood vessels, potentially increasing the risk of heart attack, stroke, and cognitive decline. Your body normally breaks down homocysteine using three B vitamins: folate (B9), B12, and B6. When folate levels are low, this process slows and homocysteine builds up.
Research shows that 400 to 800 micrograms of folate daily, combined with B12 and B6, effectively lowers elevated homocysteine. About 10 to 50 percent of people carry a genetic variant that makes it harder for their bodies to process standard folic acid, and for these individuals, the active form of folate called methylfolate (5-MTHF) may work better. Both forms are safe and inexpensive, and the combination of all three B vitamins outperforms any single vitamin alone.
One important caveat: while lowering homocysteine is well-proven, scientists have not yet definitively shown that this translates into fewer heart attacks or strokes in large clinical trials, though the evidence is promising. Dietary sources like leafy greens and legumes contain folate, but supplementation adds additional benefit beyond food alone.
Verdict: Taking a daily B-complex supplement with 400 to 800 micrograms of folate, preferably in the active methylfolate form, along with B12 and B6, is a safe, low-cost way to maintain healthy homocysteine levels based on strong research evidence.
What if there were a single blood marker, one most people have never heard of, that quietly predicts your risk of heart attack, stroke, cognitive decline, and even dementia? And what if correcting it were as straightforward as a daily B vitamin? That’s not a sales pitch. That’s what over three decades of research into homocysteine and folate is starting to tell us. The catch, as always, is in the details, because not all folate is the same, not all bodies process it equally, and the story of *how* you supplement matters almost as much as *whether* you supplement.
Let’s dig in.
Homocysteine is an amino acid, a natural byproduct of protein metabolism. Your body makes it constantly. The problem isn’t that it exists; the problem is when it builds up. Think of it like exhaust fumes from a car engine. A little is unavoidable. A lot is a sign something isn’t running cleanly.
Normally, your body converts homocysteine into other harmless compounds using three B vitamins as tools: folate (B9), B12, and B6. Folate is the most critical of the three. It donates a chemical unit called a methyl group to convert homocysteine back into methionine, a beneficial amino acid your body needs. When folate levels are low, this recycling process slows down, homocysteine accumulates in the blood, and you end up with what scientists call *hyperhomocysteinemia* (elevated homocysteine) [9].
Why does that matter? Because elevated homocysteine damages blood vessel walls through a process called oxidative stress, triggering inflammation, impairing endothelial function (the inner lining of your blood vessels), and promoting a state that makes arterial plaques more likely to form [9]. Research has also linked it to neurodegenerative conditions including Alzheimer’s disease and dementia [9].
Here’s where it gets interesting. The folate in your food, leafy greens, legumes, liver, isn’t quite the same as the synthetic folic acid found in most supplements and fortified foods. And *both* of those are different from the *active* form your cells actually use, called 5-methyltetrahydrofolate (5-MTHF). Standard folic acid has to be converted through several enzymatic steps before your body can use it. For many people, that conversion works fine. For a significant minority, it doesn’t, and that distinction could be the whole story.
At Vitacuity, our team has analysed over 1.77 million research papers to bring you the most relevant findings on this topic. Here’s what the evidence actually says.
Before we talk about solutions, let’s establish the problem. A landmark 1993 study [15] examined 44 men with moderate hyperhomocysteinemia (plasma homocysteine above 16.3 µmol/L) and compared them to 274 men with normal levels. The results were striking: 59.1% of the hyperhomocysteinemic men had suboptimal folate levels. B12 deficiency was found in 56.8%, and B6 deficiency in 25%.
In a placebo-controlled follow-up, a combined daily supplement of folic acid (1mg), B12 (0.4mg) and B6 (10mg) normalised elevated homocysteine within just 6 weeks [15].
A 1994 randomised, placebo-controlled study [10] took this further, separating out the individual vitamins. One hundred men with hyperhomocysteinemia were assigned to receive either folic acid alone (0.65mg), B12 alone (0.4mg), B6 alone (10mg), a combination of all three, or placebo for 6 weeks. The results were clear:
– Folic acid alone reduced homocysteine by 41.7% – B12 alone reduced it by 14.8% – B6 alone produced no significant reduction – The three-vitamin combination reduced it by 49.8%, not significantly different from folate alone
The conclusion? Folate deficiency is the primary nutritional cause of elevated homocysteine. B12 plays a supporting role. B6 matters less in a fasting context [10, 11].
Evidence grade: Strong, multiple RCTs, consistent findings across studies.
A 2025 systematic review and network meta-analysis [4] pooled data from 16 randomised trials to compare different supplement regimens head-to-head. Among the key findings:
– 800 µg of folic acid ranked as the most effective single-supplement dose (SUCRA score 93.7 out of 100) – 400 µg folic acid alone achieved a meaningful reduction (mean difference -0.84 µmol/L, 95% CI -1.12 to -0.56) – The combination of 1mg folic acid + 7.2mg B6 + 20µg B12 ranked highest overall (SUCRA 83.9), achieving a mean difference of -1.03 µmol/L – 400 µg folic acid + 400 µg B12 was also highly effective (-0.87 µmol/L)
Importantly, combining folate with other B vitamins was consistently superior to any single supplement alone [4].
A separate 2005 dietary analysis [11] confirmed that 400 µg of folic acid represents the minimum daily dose associated with the *maximum* homocysteine-lowering effect, roughly a 20-25% reduction. Folic acid, it noted, is more effective than dietary folate (from food) for lowering homocysteine, meaning supplementation adds value even in people eating reasonably well.
Evidence grade: Strong, network meta-analysis of 16 RCTs with clear dose-response data.
Here’s where the story gets personal. A significant proportion of the population carries a common genetic variant called MTHFR C677T. This variant reduces the efficiency of the enzyme that converts folic acid into its active form (5-MTHF), meaning standard supplements work less well for these individuals.
Roughly 10-15% of European populations are homozygous for this variant (carrying two copies, written as 677TT), and around 40-50% carry at least one copy [13]. In some populations such as Japanese, the TT genotype frequency reaches approximately 15% [13].
A 2002 double-blind trial [12] tested 400 µg/day of either standard folic acid or 5-methyltetrahydrofolate (the active form) in 20 subjects, 10 with the wild-type genotype and 10 who were homozygous for MTHFR 677TT. Both forms reduced homocysteine significantly (P<0.005). But here's the telling finding: six months after stopping supplementation, homocysteine levels remained significantly lower only in the homozygous TT subjects who had taken 5-methyltetrahydrofolate, not folic acid. The active form appeared to produce a more sustained effect in those who struggle to convert folic acid themselves.
A 2003 randomised, placebo-controlled study [14] in 167 healthy volunteers confirmed this. Over 24 weeks, both 100 µg folic acid and an equimolar dose of L-MTHF lowered homocysteine, but L-MTHF was significantly more effective (reducing homocysteine by 14.6% vs. 9.3% for folic acid; P<0.05).
The 2023 RCT [1, 5] in 272 Greek adults added another layer of nuance: when comparing folinic acid versus l-methylfolate directly, both reduced homocysteine significantly after 3 months, but the individuals with the MTHFR 677CT genotype (one copy of the variant) appeared to benefit more from folinic acid than from l-methylfolate specifically.
Evidence grade: Promising to Strong, consistent findings across RCTs, though sample sizes are modest and there is some variation by genotype and formulation.
Standard folic acid is cheap, well-studied, and effective for most people. But it comes with a caveat. Unlike 5-MTHF, folic acid requires conversion through multiple enzymatic steps. If those enzymes are impaired (due to MTHFR variants or other factors), unconverted folic acid can accumulate in the bloodstream, something researchers call unmetabolised folic acid (UMFA) [8].
The active form, (6S)5-methyltetrahydrofolate (also written as 5-MTHF or methylfolate), bypasses this conversion entirely. It enters the folate cycle directly and participates immediately in one-carbon metabolism, the biochemical pathway that governs everything from DNA synthesis to homocysteine recycling [2, 8].
A 2022 review [8] noted that 5-MTHF supplementation “can overcome the concerns about the risk for deleterious effects of UMFA related to the use of a supraphysiological dose of folic acid”, making it particularly relevant for individuals who suspect they carry MTHFR variants or who have not seen expected homocysteine reductions on standard folic acid.
A 2023 review [2] described this as the evolution of folate supplementation “from one size for all to personalised, precision, poly-paths”, acknowledging that the optimal form of folate may vary by individual.
Evidence grade: Promising, good mechanistic rationale and supportive RCT data, but more large-scale head-to-head trials in unselected populations are still needed.
The folate-homocysteine story isn’t just about cardiovascular risk. There’s a more fundamental mechanism at work. Folate is essential for producing S-adenosylmethionine (SAMe), the body’s primary methyl donor. SAMe is used for hundreds of reactions in the body, including DNA methylation: the process by which genes are switched on and off.
A 2011 study [7] investigating folic acid supplementation in patients with intermediate hyperhomocysteinemia measured not just homocysteine levels but also SAMe, S-adenosylhomocysteine (SAHcy), and genomic DNA methylation patterns. When homocysteine is elevated, SAHcy also accumulates, and SAHcy is a potent inhibitor of DNA methylation. In other words, high homocysteine doesn’t just damage blood vessels; it may disrupt the fine-tuned gene regulation your cells depend on.
Folic acid supplementation in this study increased SAMe levels and improved DNA methylation patterns alongside lowering homocysteine, suggesting benefits that go well beyond the cardiovascular markers typically measured in trials [7].
Evidence grade: Promising, intriguing mechanistic evidence, but this area needs larger studies with clinical endpoints.
Honesty matters here. The research on folate and homocysteine is genuinely impressive, but it has important gaps.
The central unresolved question is this: does *lowering* homocysteine actually translate into fewer heart attacks, strokes, and cognitive decline? Or is homocysteine simply a marker, a warning light rather than a cause? The research is conflicted.
A 2003 paper [6] put it plainly: “The benefits from lowering homocysteine levels have mainly been demonstrated in surrogate cardiovascular outcomes. The treatment of hyperhomocysteinemia cannot be firmly advocated until there are trials that demonstrate a beneficial clinical endpoint.” That was written in 2003, and while the association between elevated homocysteine and cardiovascular and neurological risk has only strengthened since, the causal proof remains incomplete.
A comprehensive 2025 review [3] of randomised controlled trials published since 1996 examined B vitamins, homocysteine lowering, and thrombotic risk reduction. The evidence for lowering homocysteine is robust. The evidence that this translates directly into reduced clinical events (heart attacks, strokes) is more complicated, some large trials showed benefit, others didn’t, and the reasons for these discrepancies likely relate to differences in baseline folate status, populations studied, and the era of the trials (many were conducted before widespread folic acid fortification, when baseline homocysteine was higher).
Other open questions: – We don’t yet know the optimal form of folate for different genetic profiles at a population scale. Most MTHFR studies have been small [12, 14]. – The long-term effects of 5-MTHF versus folic acid in people with normal MTHFR function are not fully established. – Most studies measure homocysteine as a fasting blood value, but postprandial rises in homocysteine (triggered by protein-rich meals) may also matter, and these are less studied [11]. – The relationship between folate, homocysteine, and *cognitive* decline specifically is promising but not yet definitively proven [9].
So what should a sensible, informed person in their 40s, 50s or 60s actually do with all of this?
Here’s the practical picture.
First, the basics. Folate (B9) is a water-soluble vitamin, any excess is excreted in urine. There is no meaningful risk of toxicity at supplemental doses. Supplementing daily is safe, practical, and the excess is simply excreted. The same is true for B12 and B6. There is no good reason to wait for a test before supplementing these.
Second, the numbers. The research is consistent: 400-800 µg of folate daily, combined with B12 and B6, represents the most effective nutritional intervention for maintaining healthy homocysteine levels [4, 10, 11]. The combination outperforms any single vitamin. The optimal folic acid dose for homocysteine lowering appears to be around 800 µg, beyond which you get diminishing returns [4].
Third, which form? If you’re using a standard multivitamin or B-complex with folic acid, it will work for most people. But given that approximately 10-15% of the population carries two copies of the MTHFR C677T variant (and 40-50% carry at least one copy), and given that the active form 5-MTHF is at least as effective and bypasses the conversion bottleneck entirely, there’s a reasonable case for choosing a supplement with methylfolate (5-MTHF) rather than standard folic acid, especially if you’ve supplemented with folic acid before without seeing expected results [2, 8, 12, 14].
Fourth, the real-world context. Genetic testing for MTHFR is available but can be expensive and isn’t routinely offered on the NHS. The practical alternative: simply choose the active form. It’s not meaningfully more expensive, it works for everyone regardless of genotype, and it removes the uncertainty entirely. What would a sensible, informed person do? Choose methylfolate, add B12 and B6, and supplement daily.
Fifth, diet still matters. Dark leafy greens (spinach, kale), legumes, and liver are rich in dietary folate. Supplementation is not a substitute for a reasonable diet, but the research is clear that even in people eating relatively well, folic acid supplementation adds measurable homocysteine-lowering benefit beyond what food alone achieves [11].
Finally, be aware of lifestyle factors. Coffee and tea consumption can increase homocysteine by up to 20% [11]. High-protein diets also cause transient rises. These aren’t reasons to stop drinking tea, but they’re worth knowing if you’re monitoring your levels.
The bottom line: homocysteine is one of the more actionable health markers we have. It responds reliably to nutritional intervention. The supplements involved are safe, inexpensive, and widely available. The evidence for supplementing is solid. This is a case where the sensible thing, take a good B-complex with methylfolate daily, aligns squarely with what the research suggests.
[1] Argyridou S et al. The effects of folinic acid and l-methylfolate supplementation on serum total homocysteine levels in healthy adults (2023). Clinical Nutrition ESPEN. DOI: https://doi.org/10.1016/j.clnesp.2023.09.002 | https://pubmed.ncbi.nlm.nih.gov/38056998/
[2] Wibowo N et al. The evolution of folate supplementation, from one size for all to personalized, precision, poly-paths (2023). Journal of Translational Internal Medicine. DOI: https://doi.org/10.2478/jtim-2023-0087 | https://pubmed.ncbi.nlm.nih.gov/37408570/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318921/
[3] Effects of B Vitamins on Homocysteine Lowering and Thrombotic Risk Reduction, A Review of Randomized Controlled Trials Published Since January 1996 (2025). Nutrients. DOI: https://doi.org/10.3390/nu17071122 | https://pubmed.ncbi.nlm.nih.gov/40218880/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11990291/
[4] Effect of Nutritional Supplements for Reducing Homocysteine Levels in Healthy Adults: A Systematic Review and Network Meta-Analysis of Randomized Trials (2025). Nutrition Reviews. DOI: https://doi.org/10.1093/nutrit/nuae191 | https://pubmed.ncbi.nlm.nih.gov/39960689/ | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12166197/
[5] Argyridou S et al. The effects of folinic acid and l-methylfolate supplementation on serum total homocysteine levels in healthy adults (2023). Clinical Nutrition ESPEN. DOI: https://doi.org/10.1016/j.clnesp.2023.09.002 | https://pubmed.ncbi.nlm.nih.gov/38056998/
[6] Lussier-Cacan S et al. Management of hyperhomocysteinemia (2003). https://pubmed.ncbi.nlm.nih.gov/18370637/
[7] Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia (2011). https://pubmed.ncbi.nlm.nih.gov/21697534/
[8] Greenberg JA et al. Folate Supplementation in Fertility and Pregnancy: The Advantages of (6S)5-Methyltetrahydrofolate (2022). https://pubmed.ncbi.nlm.nih.gov/35653630/
[9] Winkler R et al. Homocysteine and B vitamins (2005). DOI: https://doi.org/10.1007/3-540-27661-0_11 | https://pubmed.ncbi.nlm.nih.gov/16596805/
[10] Ubbink JB et al. Vitamin requirements for the treatment of hyperhomocysteinemia in humans (1994). Journal of Nutrition. https://pubmed.ncbi.nlm.nih.gov/7931701/
[11] Dietary determinants of plasma homocysteine concentrations (2005). Thrombosis and Haemostasis. DOI: https://doi.org/10.1055/s-2005-872397 | https://pubmed.ncbi.nlm.nih.gov/16047264/
[12] Fohr IP et al. Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C→T polymorphism of methylenetetrahydrofolate reductase (2002). European Journal of Nutrition. DOI: https://doi.org/10.1046/j.1365-2362.2002.01055.x | https://pubmed.ncbi.nlm.nih.gov/12486865/
[13] Genetic polymorphisms and folate status (2017). Congenital Anomalies. https://pubmed.ncbi.nlm.nih.gov/28598562/
[14] Lamers Y et al. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study (2003). American Journal of Clinical Nutrition. DOI: https://doi.org/10.1093/ajcn/77.3.658 | https://pubmed.ncbi.nlm.nih.gov/12600857/
[15] Ubbink JB et al. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia (1993). American Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/8416664/
This article is for informational purposes only and does not constitute medical advice. Food supplements should not be used as a substitute for a varied and balanced diet and healthy lifestyle. If you are pregnant, breastfeeding, taking medication or have a medical condition, consult your doctor before taking any supplement. These statements have not been evaluated by the Food and Drug Administration (FDA) or the Medicines and Healthcare products Regulatory Agency (MHRA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Quick Read NAD+ is a molecule your cells need to produce energy. As you age, NAD+ levels drop significantly, partly
Quick Read Ginkgo biloba’s reputation as a memory supplement is more complicated than headlines suggest. Research shows it does not
Free guide: The research behind brain health supplements
Plus our weekly research digest — straight to your inbox.
Just leave your email address.